Publication Type:

Journal Article

Source:

Journal of Clinical and Diagnostic Research, Volume 5, Number 3, p.625-627 (2011)

URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-79959308417&partnerID=40&md5=d98dc8698fc10a029ebf3d76a3e987d4

Keywords:

adult, article, blood smear, bone marrow biopsy, case report, clinical examination, corticosteroid, coughing, dexamethasone, diethylcarbamazine, disease severity, echography, eosinophil count, Filaria, FIP1 like 1 protein, gene mutation, heart murmur, hemoglobin, human, human tissue, hypereosinophilic syndrome, imatinib, leukocyte differential count, male, mitral valve regurgitation, outcome assessment, pallor, platelet derived growth factor alpha receptor, prednisolone, pulmonary hypertension, reverse transcription polymerase chain reaction, smoking cessation, splenomegaly, thorax radiography, thrombocyte count, tricuspid valve regurgitation, two dimensional echocardiography, unclassified drug, wheezing

Abstract:

In India, a clinical and/or a laboratory diagnosis of hypereosinophilia is very common and is usually attributed to parasitic infestations (viz helminthiasis and filariasis) or atopy. The treatment usually includes deworming or antifilarial drugs in the filaria endemic regions. We report here, a case of hypereosinophilic syndrome in a middle-aged man, who presented with features which mimicked asthma with eosinophilia that did not respond to the routine treatment measures. He was found to have a FIP1L1-PDGFR-α mutation and he improved on treatment with the small molecule, tyrosine kinase inhibitor, Imatinib that is commonly used in patients with malignant diseases of haematological origin.

Notes:

cited By (since 1996)0

Cite this Research Publication

A. Aa Mehta, Jose, Wb, and Pavithran, Kb, “Hyperesoinophilic syndrome with FIP1L1 PDGFRα mutation: A case study”, Journal of Clinical and Diagnostic Research, vol. 5, pp. 625-627, 2011.